BioCentury
ARTICLE | Clinical News

GM-CT-01: Phase I/II started

May 21, 2012 7:00 AM UTC

Cancer Centre at the Cliniques Universitaires Saint-Luc and LICR are funding the first stage, while Galectin is responsible for funding the second portion. ...